ID   OV-MZ-03
AC   CVCL_X952
SY   OV-MZ-3; OVarian-MainZ-03
DR   Wikidata; Q54936851
RX   PubMed=1500230;
RX   PubMed=11925137;
CC   Doubling time: 52 hours (PubMed=1500230).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 5
//
RX   PubMed=1500230; DOI=10.1002/ijc.2910520115;
RA   Mobus, Volker Jochen
RA   Gerharz, Claus-Dieter
RA   Press, U.
RA   Moll, Roland
RA   Beck, Timothy
RA   Mellin, Walter
RA   Pollow, Kunhard
RA   Knapstein, Paul-Georg
RA   Kreienberg, Rolf
RT   "Morphological, immunohistochemical and biochemical characterization
RT   of 6 newly established human ovarian carcinoma cell lines.";
RL   Int. J. Cancer 52:76-84(1992).
//
RX   PubMed=11925137; DOI=10.1006/gyno.2002.6597;
RA   Oppitz, Matthias
RA   Mobus, Volker Jochen
RA   Brock, S.
RA   Drews, Ulrich
RT   "Muscarinic receptors in cell lines from ovarian carcinoma: negative
RT   correlation with survival of patients.";
RL   Gynecol. Oncol. 85:159-164(2002).
//